Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS)
CNY 31.5
(0.77%)
CNY 31.5
(0.77%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.39 Billion CNY | 0.51% |
| 2022 | 1.39 Billion CNY | 1.98% |
| 2021 | 1.36 Billion CNY | 5.68% |
| 2020 | 1.29 Billion CNY | 140.21% |
| 2019 | 537.96 Million CNY | 12.88% |
| 2018 | 476.56 Million CNY | 15.65% |
| 2017 | 412.05 Million CNY | 15.42% |
| 2016 | 357.02 Million CNY | 0.0% |
| 2013 | 257.13 Million CNY | 33.98% |
| 2012 | 191.91 Million CNY | 72.28% |
| 2011 | 111.4 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.37 Billion CNY | 0.59% |
| 2024 Q1 | 1.36 Billion CNY | -2.83% |
| 2024 Q2 | 1.36 Billion CNY | 0.54% |
| 2023 Q2 | 1.36 Billion CNY | -0.67% |
| 2023 Q3 | 1.38 Billion CNY | 1.4% |
| 2023 Q1 | 1.37 Billion CNY | -1.5% |
| 2023 FY | 1.39 Billion CNY | 0.51% |
| 2023 Q4 | 1.39 Billion CNY | 1.31% |
| 2022 Q2 | 1.35 Billion CNY | -1.29% |
| 2022 Q1 | 1.37 Billion CNY | 0.65% |
| 2022 FY | 1.39 Billion CNY | 1.98% |
| 2022 Q4 | 1.39 Billion CNY | 1.31% |
| 2022 Q3 | 1.37 Billion CNY | 1.31% |
| 2021 Q1 | 1.31 Billion CNY | 1.94% |
| 2021 Q3 | 1.33 Billion CNY | 2.62% |
| 2021 FY | 1.36 Billion CNY | 5.68% |
| 2021 Q4 | 1.36 Billion CNY | 2.28% |
| 2021 Q2 | 1.3 Billion CNY | -1.23% |
| 2020 Q4 | 1.29 Billion CNY | 4.26% |
| 2020 Q2 | 581.35 Million CNY | 11.9% |
| 2020 Q1 | 519.53 Million CNY | -3.43% |
| 2020 FY | 1.29 Billion CNY | 140.21% |
| 2020 Q3 | 1.23 Billion CNY | 113.21% |
| 2019 Q2 | 498.22 Million CNY | 0.0% |
| 2019 FY | 537.96 Million CNY | 12.88% |
| 2019 Q4 | 537.96 Million CNY | 0.0% |
| 2018 FY | 476.56 Million CNY | 15.65% |
| 2017 FY | 412.05 Million CNY | 15.42% |
| 2016 FY | 357.02 Million CNY | 0.0% |
| 2014 Q3 | 270.88 Million CNY | 0.0% |
| 2013 FY | 257.13 Million CNY | 33.98% |
| 2012 FY | 191.91 Million CNY | 72.28% |
| 2011 FY | 111.4 Million CNY | 0.0% |